Zim Integrated Shipping Serv

U.S. equity futures declined Tuesday amid AI disruption fears and geopolitical focus. For novice investors, the backdrop features falling fund costs but rising market uncertainty.

Precigen (PGEN) shares surged 14% as Q1 revenue of $23.3M beat estimates, fueled by $21.6M from Papzimeos. Net loss narrowed to $7.9M from $54.2M a year ago.

Zimmer Biomet shares dropped 9% Tuesday after beating Q1 estimates and raising its 2026 profit forecast, as investors focused on an unchanged sales outlook and the CFO's exit.